Compound 1814
Identifiers
- Canonical SMILES:
CCOc1cccc(c1)-c1c(C)noc1C
- IUPAC name:
4-(3-ethoxyphenyl)-3,5-dimethyl-1,2-oxazole
- InChi:
InChI=1S/C13H15NO2/c1-4-15-12-7-5-6-11(8-12)13-9(2)14-16-10(13)3/h5-8H,4H2,1-3H3
- InChiKey:
WXDQJUHQGQVRKB-UHFFFAOYSA-N
External links
![]() 54757749 |
![]() CHEMBL1828981 |
ODR |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
3 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
Bromodomain / Histone | 5.13 | breast cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 217.11 g/mol | |||
HBA | 3 | |||
HBD | 0 | |||
HBA + HBD | 3 | |||
AlogP | 2.52 | |||
TPSA | 35.26 | |||
RB | 3 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 3 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
10.1021/jm200640v | 3c | CBP Q92793 |
H4 P62805 |
Biochemical assay | alphascreen BRD4 | pIC50 (half maximal inhibitory concentration, -log10) | 4.63 | |
10.1021/jm200640v | 3c | CBP Q92793 |
H4 P62805 |
Biochemical assay | alphascreen BRD2 | pIC50 (half maximal inhibitory concentration, -log10) | 5.13 | |
10.1021/jm200640v | 3c | CBP Q92793 |
H4 P62805 |
Biochemical assay | alphascreen CREBBP | pIC50 (half maximal inhibitory concentration, -log10) | 4.06 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.5738 | Valdecoxib | DB00580 | |
0.4828 | Parecoxib | DB08439 | |
0.4409 | 5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-(4-METHOXYPHENYL)ISOXAZOLE-3-CARBOXAMIDE | DB06964 | |
0.4099 | 2,6-DIMETHYL-1-(3-[3-METHYL-5-ISOXAZOLYL]-PROPANYL)-4-[2-METHYL-4-ISOXAZOLYL]-PHENOL | DB08715 | |
0.4000 | 5-(3-{3-[3-HYDROXY-2-(METHOXYCARBONYL)PHENOXY]PROPENYL}PHENYL)-4-(HYDROXYMETHYL)ISOXAZOLE-3-CARBOXYLIC ACID | DB08001 | |
0.4000 | AUY922 | DB11881 | |
0.3970 | 5-(5-chloro-2,4-dihydroxyphenyl)-N-ethyl-4-[4-(morpholin-4-ylmethyl)phenyl]isoxazole-3-carboxamide | DB06961 | |
0.3956 | PX-102 | DB15416 | |
0.3867 | 2,6-DIMETHYL-1-(3-[3-METHYL-5-ISOXAZOLYL]-PROPANYL)-4-[2N-METHYL-2H-TETRAZOL-5-YL]-PHENOL | DB08713 | |
0.3777 | Alobresib | DB14970 | |
0.3740 | 3-(6-HYDROXY-NAPHTHALEN-2-YL)-BENZO[D]ISOOXAZOL-6-OL | DB07236 | |
0.3714 | 3-phenyl-5-(1H-pyrazol-3-yl)isoxazole | DB07613 | |
0.3556 | Isocarboxazid | DB01247 | |
0.3554 | Pleconaril | DB05105 | |
0.3537 | 5-(5-(4-(4,5-dihydro-2-oxazoly)phenoxy)pentyl)-3-methyl osoxazole | DB08720 |